Siu Hong Dexter Wong

Prof. Siu Hong Dexter Wong

Department of Biomedical Engineering, the Hong Kong Polytechnic University
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
BYBoguang Yang
Boguang Yang
Kongchang WeiKongchang Wei
Kongchang Wei
Claudia LoebelClaudia Loebel
Claudia Loebel
Kunyu ZhangKunyu Zhang
Kunyu Zhang
QFQian Feng
Qian Feng
Liming BianLiming Bian
Liming Bian
3D culture of cells in designer biomaterial matrices provides a biomimetic cellular microenvironment and can yield critical insights into cellular behaviours not available from conventional 2D cultures. Hydrogels with dynamic properties, achieved by incorporating either degradable structural components or reversible dynamic crosslinks, enable efficient cell adaptation of the matrix and support associated cellular functions. Herein we demonstrate that given similar equilibrium binding constants, hydrogels containing dynamic crosslinks with a large dissociation rate constant enable cell force-induced network reorganization, which results in rapid stellate spreading, assembly, mechanosensing, and differentiation of encapsulated stem cells when compared to similar hydrogels containing dynamic crosslinks with a low dissociation rate constant. Furthermore, the static and precise conjugation of cell adhesive ligands to the hydrogel subnetwork connected by such fast-dissociating crosslinks is also required for ultra-rapid stellate spreading (within 18 h post-encapsulation) and enhanced mechanosensing of stem cells in 3D. This work reveals the correlation between microscopic cell behaviours and the molecular level binding kinetics in hydrogel networks. Our findings provide valuable guidance to the design and evaluation of supramolecular biomaterials with cell-adaptable properties for studying cells in 3D cultures.

1 January 2022 in Theranostics
Verified
Journal Article
Open access
BYBohan Yin
Bohan Yin
JNJunguo Ni
Junguo Ni
CWClaire E. Witherel
Claire E. Witherel
MYMo Yang
Mo Yang
Jason BurdickJason Burdick
Jason Burdick
Siu Hong Dexter WongSiu Hong Dexter Wong
Siu Hong Dexter Wong
Osteoarthritis (OA) is a prevalent chronic whole-joint disease characterized by low-grade systemic inflammation, degeneration of joint-related tissues such as articular cartilage, and alteration of bone structures that can eventually lead to disability. Emerging evidence has indicated that synovium or articular cartilage-secreted extracellular vesicles (EVs) contribute to OA pathogenesis and physiology, including transporting and enhancing the production of inflammatory mediators and cartilage degrading proteinases. Bioactive components of EVs are known to play a role in OA include microRNA, long non-coding RNA, and proteins. Thus, OA tissues-derived EVs can be used in combination with advanced nanomaterial-based biosensors for the diagnostic assessment of OA progression. Alternatively, mesenchymal stem cell- or platelet-rich plasma-derived EVs (MSC-EVs or PRP-EVs) have high therapeutic value for treating OA, such as suppressing the inflammatory immune microenvironment, which is often enriched by pro-inflammatory immune cells and cytokines that reduce chondrocytes apoptosis. Moreover, those EVs can be modified or incorporated into biomaterials for enhanced targeting and prolonged retention to treat OA effectively. In this review, we explore recently reported OA-related pathological biomarkers from OA joint tissue-derived EVs and discuss the possibility of current biosensors for detecting EVs and EV-related OA biomarkers. We summarize the applications of MSC-EVs and PRP-EVs and discuss their limitations for cartilage regeneration and alleviating OA symptoms. Additionally, we identify advanced therapeutic strategies, including engineered EVs and applying biomaterials to increase the efficacy of EV-based OA therapies. Finally, we provide our perspective on the future of EV-related diagnosis and therapeutic potential for OA treatment.

15 November 2018 in ACS Nano
Verified
Journal Article
Closed access
CYChao Yin
Chao Yin
GWGuohua Wen
Guohua Wen
CLChao Liu
Chao Liu
BYBoguang Yang
Boguang Yang
SLSien Lin
Sien Lin
Liming BianLiming Bian
Liming Bian

5 March 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
JHJing Huang
Jing Huang
BYBIN YANG
BIN YANG
YPYuan Peng
Yuan Peng
JHJinsheng Huang
Jinsheng Huang
Siu Hong Dexter WongSiu Hong Dexter Wong
Siu Hong Dexter Wong
SHShisong Han
Shisong Han

27 February 2017 in Nano Letters
Verified
Journal Article
Closed access
Siu Hong Dexter WongSiu Hong Dexter Wong
Siu Hong Dexter Wong
JLJinming Li
Jinming Li
XYXiaohui Yan
Xiaohui Yan
BWBen Wang
Ben Wang
RLRui Li
Rui Li
Liming BianLiming Bian
Liming Bian

1 November 2017 in Biomaterials
Verified
Journal Article
Closed access
RLRui Li
Rui Li
Jian-Bin XuJian-Bin Xu
Jian-Bin Xu
Siu Hong Dexter WongSiu Hong Dexter Wong
Siu Hong Dexter Wong
JLJinming Li
Jinming Li
PZPengchao Zhao
Pengchao Zhao
Liming BianLiming Bian
Liming Bian